Taylor, H. B., Klaeger, S., Clauser, K. R., Sarkizova, S., Weingarten-Gabbay, S., Graham, D. B., . . . Abelin, J. G. (2021). MS-Based HLA-II Peptidomics Combined With Multiomics Will Aid the Development of Future Immunotherapies. Mol Cell Proteomics.
Chicago Style aipamenaTaylor, Hannah B., Susan Klaeger, Karl R. Clauser, Siranush Sarkizova, Shira Weingarten-Gabbay, Daniel B. Graham, Steven A. Carr, and Jennifer G. Abelin. "MS-Based HLA-II Peptidomics Combined With Multiomics Will Aid the Development of Future Immunotherapies." Mol Cell Proteomics 2021.
MLA aipamenaTaylor, Hannah B., et al. "MS-Based HLA-II Peptidomics Combined With Multiomics Will Aid the Development of Future Immunotherapies." Mol Cell Proteomics 2021.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.